Skip to main content
DIRUI INDUSTRIAL CO.,LTD. logo

DIRUI INDUSTRIAL CO.,LTD. — Investor Relations & Filings

Ticker · 300396 ISIN · CNE100001XS7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,689 across all filing types
Latest filing 2023-12-26 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 300396

About DIRUI INDUSTRIAL CO.,LTD.

https://www.dirui.com.cn

DIRUI INDUSTRIAL CO.,LTD. specializes in the research, development, manufacturing, and distribution of medical laboratory instruments and diagnostic reagents. The company provides comprehensive solutions for in-vitro diagnostics (IVD), focusing on several key clinical areas including urinalysis, biochemistry, hematology, and chemiluminescence immunoassay. Its product portfolio features high-throughput automated analyzers and integrated laboratory systems designed to enhance diagnostic efficiency and accuracy. DIRUI serves a global market, providing medical institutions and laboratories with a wide range of diagnostic tools, from urine sediment analysis to vaginal secretion testing. The company emphasizes technological innovation and quality control to support clinical decision-making and patient care through reliable laboratory automation and standardized testing protocols.

Recent filings

Filing Released Lang Actions
2023年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed announcement of the resolutions passed at the 2023 second extraordinary shareholders meeting of the company. It includes voting results on various proposals such as board of directors elections, supervisory board elections, share repurchase, capital reduction, and amendments to company bylaws. The document also confirms the legality and validity of the meeting and voting process with a legal opinion. There is no financial data or report content, but rather the official results of shareholder votes at a general meeting. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements (DVA)'. The document length is over 5,000 characters and contains substantive voting results, not just a brief announcement or a report publication notice.
2023-12-26 Chinese
第六届董事会第一次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of the resolutions passed at the first meeting of the sixth board of directors of Dirui Medical Technology Co., Ltd. It includes details about the election of the chairman, appointment of audit committee members, senior management appointments, and approval of using idle funds for purchasing financial products. The document contains voting results and biographies of the appointed directors and senior management. It is a formal announcement related to changes in the company's board and senior management, not a full report or financial statement. Therefore, it fits the category of Board/Management Information (MANG). The document length is 6643 characters, which is sufficient for a detailed announcement but does not contain financial statements or other report types. Hence, the classification is MANG with high confidence.
2023-12-26 Chinese
关于董事会、监事会完成换届选举及聘任高级管理人员、其他相关人员的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the completion of the board of directors and supervisory board re-election, appointment of senior management, and other related personnel changes. It details the composition of the new board, audit committee, supervisory board, and lists the newly appointed senior management personnel. It also mentions the departure of some previous board members and management due to term expiration. There is no financial data, no report or presentation attached, and the document focuses solely on management and board changes. Therefore, this fits the category of Board/Management Information (MANG). The document length is short and it is not a report publication announcement or regulatory filing. Confidence is high due to clear content about board and management changes.
2023-12-26 Chinese
关于公司医疗器械注册证变更的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by a company (迪瑞医疗科技股份有限公司) regarding changes to medical device registration certificates issued by regulatory authorities (国家药品监督管理局 and 吉林省药品监督管理局). It lists detailed changes to product registrations, including registration numbers, validity periods, and changes in product specifications and applicable instruments. The document is an official announcement about regulatory approvals and changes to product registrations, not a financial report, earnings release, or management discussion. It does not contain financial data, management changes, voting results, or legal proceedings. It is a regulatory announcement about product registration changes, which fits best under the category of Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-12-26 Chinese
关于获得发明专利证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of four invention patent certificates issued by the Chinese National Intellectual Property Administration. It details patent numbers, inventors, application dates, and the significance of the patents to the company's product lines. There is no financial data, no mention of annual or quarterly reports, no voting results, no management changes, no earnings information, or any other regulatory filing type. The document is a formal announcement of intellectual property achievements, which does not fit into any of the specific financial or corporate filing categories. Therefore, it falls under the fallback category of Regulatory Filings (RNS). The document length is short (1333 characters), and it is a direct announcement, not a report publication notice.
2023-12-26 Chinese
关于减少注册资本暨债权人通知的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from a company regarding the reduction of registered capital and notification to creditors. It details decisions made in board meetings about share repurchases and capital reduction, amendments to the company charter, and creditor notification procedures. There are no financial statements or detailed financial performance data included. The document is primarily a formal announcement about corporate actions related to capital structure and legal compliance, not a full financial report or earnings release. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is short and it is not merely announcing the publication of a report, so it is not RPA or RNS.
2023-12-26 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.